Fisher Drug Discovery Resource Center
Therapeutic Approaches: Biologics, Small Molecules, Antibodies, Stem Cells, , Covid-19
Therapeutic Areas of Expertise: Cardiology, Immunology, Infectious Diseases, Metabolic Disorders, Neurological Disorders, Oncology, Ophthalmology, Psychiatric Disorders, Regenerative Medicine, Virology
Center/Program Highlights:
The Fisher Drug Discovery Resource Center (DDRC) guides researchers in drug discovery by improving the efficiency of their bioassays, identifying compounds and targets of function, and in utilizing technologies for the measurement of drug/receptor interactions. The center has a collection of 420,000 compounds, automated liquid transfer devices, compound databases, and supports a broad diversity of assay development techniques, typically found in early drug discovery programs. The Center also has spectroscopic and calorimetric equipment for use in studies of the interactions of drugs with their targets. (RRID:SCR_020985)
Sources of Funding: Philanthropy, Disease Foundations, University, Revenue
Institutional Affiliation(s): The Rockefeller University, Weill Cornell Medical College
Address:
1230 York Ave
Box 203
New York
New York, 10065
United States
Center/Program Start Date: 2003
Number of Employees: 5
